Beneficial Effect of Female Gender on Long-Term Survival After Heart Transplantation
Authors:
- Nicola E. HiemannNHNicola E. Hiemann
- Christoph KnosallaCKChristoph Knosalla
- Ernst WellnhoferEWErnst Wellnhofer
- Hans B. LehmkuhlHLHans B. Lehmkuhl
- Roland HetzerRHRoland Hetzer
- Rudolf MeyerRMRudolf Meyer
- 27 July 2008
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 86 (2) , 348-356
Abstract
We aimed to test whether stenotic microvasculopathy affects the more beneficial course in female cardiac transplant recipients. We studied 873 patients (35/151 premenopausal women aged < or =40 years) who underwent primary heart transplantation. In 7750 biopsies harvested within the first posttransplant year endothelial disease and stenotic microvasculopathy were evaluated by light microscopy (Hematoxylin and Eosin). Kaplan-Meier and Cox regression analyses were performed for major cardiac events (MACE; lethal myocardial infarction, sudden cardiac death, graft failure, and cardiac retransplantation). Stenotic microvasculopathy was found equally in men (38%) and women (39%). Allografts from premenopausal female-to-male transplants more frequently developed endothelial disease (78% vs. 65%; P=0.021) and stenotic microvasculopathy (46% vs. 28%, P=0.024). Beyond the first 5 posttransplant years women presented MACE less often than men, independently of donor gender and stenotic microvasculopathy (P=0.0001). Multivariate regression analysis found women to be at lower risk for MACE (Relative Risk [RR] 0.38; 95% Confidence Interval [CI] 0.17-0.81), whereas stenotic microvasculopathy (RR 2.15; 95% CI 1.42-3.26) and treated diabetes (RR 1.65; 95% CI 1.08-2.52) indicated a higher risk for MACE. Stenotic microvasculopathy has prognostic impact on survival of male and female cardiac recipients; however, it does not affect the more beneficial course of women in the long-term follow-up.Keywords
This publication has 25 references indexed in Scilit:
- Prognostic Impact of Microvasculopathy on Survival After Heart TransplantationCirculation, 2007
- Registry of the International Society for Heart and Lung Transplantation: Twenty-third Official Adult Heart Transplantation Report—2006The Journal of Heart and Lung Transplantation, 2006
- Outcome Analysis of Donor Gender in Heart TransplantationThe Journal of Heart and Lung Transplantation, 2006
- The Impact of Donor Gender on Cardiac Peri-transplantation Ischemia InjuryThe Journal of Heart and Lung Transplantation, 2005
- Small vessel disease after heart transplantation: impact of immunologic and nonimmunologic risk factors*Transplant International, 2005
- The influence of donor gender on allograft vasculopathy: Evidence from intravascular ultrasoundTransplantation Proceedings, 2004
- Diagnostic accuracy of coronary angiography and risk factors for post–heart-transplant cardiac allograft vasculopathyTransplantation, 2003
- Capillary endothelia and cardiomyocytes differ in vulnerability to ischemia/reperfusion during clinical heart transplantationEuropean Journal of Cardio-Thoracic Surgery, 2001
- Cardiac Allograft VasculopathyCirculation, 1997
- RISK FACTOR ANALYSIS FOR THE MAJOR HAZARDS FOLLOWING HEART TRANSPLANTATION—REJECTION, INFECTION, AND CORONARY OCCLUSIVE DISEASETransplantation, 1991